Market Trends of Germany Nuclear Imaging Industry
This section covers the major market trends shaping the Germany Nuclear Imaging Market according to our research experts:
Oncology is Expected to Witness Significant Share in Application Segment
Cancer is one of the leading causes of morbidity and mortality in Germany. The burden of cancer is rising every year as more people are being diagnosed with cancer in the country.
According to the 2020 Globocan report, there were 274,364 new cancer cases diagnosed and 86,684 deaths due to cancer in 2020. Adding to that, the number of prevalent cases (5 years) of cancer was 2,188,176. The most common cancers in Germany are lung cancer, prostate cancer, bladder cancer, colorectum cancer, and skin cancer. Similarly, as per the Robert Koch Institute, 2021 data, approximately 16,500 patients develop kidney cancer in Germany each year. The rising cases of cancer in the country are augmenting the demand for better diagnosis in the early stages of the disease. As nuclear imaging is one of the most reliable diagnostic methods for cancers, it is believed that the market for nuclear imaging will witness strong growth over the forecast period.
Furthermore, data published by the University Hospital of Würzburg, Germany in 2021 suggests that FDG PET/CT imaging had a high negative predictive value in detecting cervical lymph node metastasis in patients with newly diagnosed, treatment-naive Squamous Cell carcinoma of the oral cavity. The scans can also detect metastasis proving the multiple uses of these tests. Hence, the effectiveness of PET CT scan in the diagnosis of certain cancers is augmenting its demand across the country.